Table 1.
Case | Sex | Age (years) | Ethiology | Eyesight | Paresis | Aphasia | Lesion–test interval (months) |
---|---|---|---|---|---|---|---|
AK | F | 27 | Stroke | + | + | 12 | |
AS | M | 49 | Bleeding and trauma | Myopic | − | − | 43 |
HR | M | 54 | Stroke | Presbyopic | + | + | 25 |
GZ | M | 58 | Stroke | Hyperopic | − | + | 2.5 |
RM | M | 42 | Stroke | Myopic | − | − | 12.5 |
MS | F | 25 | Tumor, encephalitis | Hyperopic | − | − | 192 |
MM | F | 43 | Stroke | Hyperopic | − | + | 3 |
RF | M | 43 | Stroke | + | + | 3 | |
WD | M | 61 | Stroke | Presbyopic | + | − | 209 |
MH | M | 25 | Tumor | Myopic | − | − | 53 |
SL | F | 45 | Stroke | − | − | 4 | |
KH | M | 24 | Hematoma | + | − | 14 | |
KB | M | 55 | Tumor | Myopic | − | − | 29 |
GK | M | 56 | Stroke | + | + | 116 | |
AH | F | 45 | Tumor | − | − | 5 | |
DW | F | 41 | Stroke | Left eye deficit | + | + | 20 |
IH | F | 34 | Stroke | Myopic | + | − | 47 |
MK | F | 62 | Ischemia | Myopic | − | − | 1.5 |
EL | M | 72 | Stroke | Presbyopic | + | + | 2 |
UH | M | 25 | Stroke | − | − | 3 | |
RB | F | 43 | Tumor | Myopic | − | − | 16 |
HP | M | 52 | Stroke | − | − | 2 | |
EP | F | 40 | Stroke | Hyperopic | + | − | 113 |
LG | M | 36 | Stroke | − | − | 55 | |
GR | F | 59 | Stroke | − | − | 108 | |
ML | M | 36 | Stroke | − | − | 4 | |
IL | F | 62 | Stroke | Myopic | + | + | 84 |
Included are gender, age, ethology of the lesion, visual acuity in both eyes, the presence of paresis or aphasia (indicated by a +), and the interval between the lesion and the testing.